Chronic Kidney Disease News and Research

Latest Chronic Kidney Disease News and Research

Researchers identify potential approach to eliminate race from equations to estimate kidney function

Researchers have identified an approach to remove race from equations used to estimate a person's kidney function. These equations have been criticized for potentially perpetuating racial health disparities. The findings, reported September 23 in the New England Journal of Medicine, are expected to inform National Kidney Foundation–American Society of Nephrology Task Force guidelines on evaluating kidney function.

24 Sep 2021

Detecting early outcomes in COVID-19 patients

A new Nature study aimed to predict clinical data of COVID-19 patients based on clinical outcomes.

21 Sep 2021

Review: Long COVID symptoms rarely persisted beyond 12 weeks in young people

Long COVID symptoms rarely persisted beyond 12 weeks in children and adolescents, unlike adults. But more studies were required to investigate the risk and impact of long COVID in young people to help guide vaccine policy decisions in Australia, according to a review led by the Murdoch Children's Research Institute (MCRI).

17 Sep 2021

Justice Department targets data mining in Medicare Advantage fraud case

The Justice Department has accused an upstate New York health insurance plan for seniors and its medical analytics company of cheating the government out of tens of millions of dollars.

14 Sep 2021

Study reveals Pfizer/BioNTech and Oxford/AstraZeneca COVID-19 vaccine efficacy and immune response in clinically vulnerable individuals

The current study found that a strong S-antibody response occurs following complete vaccination with two different COVID-19 vaccines.

6 Sep 2021

COVID-19 associated with increased risk of kidney damage, end-stage kidney diseases

A study by researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System shows that people who have had COVID-19, including those with mild cases, are at an increased risk of developing kidney damage as well as chronic and end-stage kidney diseases.

1 Sep 2021

Low-sodium alternative for salt lowers stroke risk

Replacing salt with a low-sodium alternative lowers the risk of stroke in people with high blood pressure or prior stroke, according to late breaking research presented in a Hot Line session today at ESC Congress 2021 and published in the New England Journal of Medicine.

30 Aug 2021

UH associate professor receives $2.5 million to explore how arterial hardening starts within cells

In diseases such as hypertension, aging, atherosclerosis, diabetes and chronic kidney disease, arterial calcification and stiffening of the elastic layer of the arterial wall are almost always present.

30 Aug 2021

‘My time to live’: Through novel program, kidney patients get palliative care, dialysis ’til the end

After a decade of living with chronic kidney disease, Vonita McGee knows her body is wearing out.

30 Aug 2021

New ESC guidelines for diagnosis and treatment of heart failure published

The European Society of Cardiology Guidelines for the diagnosis and treatment of acute and chronic heart failure are published online today in European Heart Journal.

27 Aug 2021

Researchers recommend urgent adaptation plans to mitigate heat-related deaths and illnesses

Extreme heat is an increasingly common occurrence worldwide, with heat-related deaths and illnesses also expected to rise.

20 Aug 2021

Urine test for detecting chronic kidney disease is not used enough in high-risk groups, study suggests

Despite their higher risk of chronic kidney disease, people with hypertension or diabetes usually are not given a simple test for protein in the urine to screen for this potentially deadly disorder, according to a study led by researchers at Johns Hopkins Bloomberg School of Public Health.

19 Aug 2021

UC Davis Health offers third dose COVID-19 'booster' shots to immunocompromised patients

As COVID-19 cases rise due to the Delta variant, the Centers for Disease Control (CDC) has approved third dose vaccinations for patients whose immune systems are compromised moderately to severely.

17 Aug 2021

Excluding race factor from kidney function estimates may affect clinical outcomes for Black cancer patients

Removing race as a factor in a kidney function-estimating equation used to guide cancer treatment dosing and eligibility may decrease the proportion of Black patients recommended to receive full doses of anticancer drugs.

16 Aug 2021

Study unlocks genetic treasure chest for chronic kidney disease

Despite impacting an estimated 850 million people and being responsible for 1 in 60 deaths worldwide, few treatments are available for chronic kidney disease.

12 Aug 2021

Oral drug found to be effective, safe for treating anemia in patients with chronic kidney disease

Pooled results from recent clinical trials indicate that an oral drug called roxadustat is an effective treatment for anemia in patients with chronic kidney disease.

6 Aug 2021

Clarity on covid count: Pandemic’s toll on seniors extended well beyond nursing homes

As covid-19 resurges across the country, driven by the highly infectious delta variant, experts are extending our understanding of the pandemic's toll on older adults — the age group hit hardest by the pandemic.

6 Aug 2021

New model can help clinicians to predict 40-day mortality risk in hospitalized COVID-19 patients

Researchers from Hackensack Meridian University Medical Center and Berry Consultants, LLC, Austin, Texas have developed a new model to help clinicians predict the risk of death within 40 days in patients who are hospitalized with COVID-19 infection.

2 Aug 2021

Study compares the impacts of various race-free equations on kidney disease diagnoses

Equations that estimate individuals' kidney function currently include an adjustment for race. A study appearing in an upcoming issue of JASN compares various race-free equations and their expected impacts on kidney disease diagnoses.

29 Jul 2021

New concise recommendations for managing osteoporosis in patients with chronic kidney disease

Patients with advanced chronic kidney disease (CKD) typically suffer from impaired bone quality and quantity, with a non-vertebral fracture risk which is 4-to 6-fold higher than the fracture risk of matched controls. However, despite their high risk of fragility fractures, the vast majority of patients with chronic CKD stages 4 to 5D, are not receiving osteoporosis therapy.

15 Jul 2021

Chronic Kidney Disease News and Research

Latest Chronic Kidney Disease News and Research

Researchers identify potential approach to eliminate race from equations to estimate kidney function

Detecting early outcomes in COVID-19 patients

Review: Long COVID symptoms rarely persisted beyond 12 weeks in young people

Justice Department targets data mining in Medicare Advantage fraud case

Study reveals Pfizer/BioNTech and Oxford/AstraZeneca COVID-19 vaccine efficacy and immune response in clinically vulnerable individuals

COVID-19 associated with increased risk of kidney damage, end-stage kidney diseases

Low-sodium alternative for salt lowers stroke risk

UH associate professor receives $2.5 million to explore how arterial hardening starts within cells

‘My time to live’: Through novel program, kidney patients get palliative care, dialysis ’til the end

New ESC guidelines for diagnosis and treatment of heart failure published

Researchers recommend urgent adaptation plans to mitigate heat-related deaths and illnesses

Urine test for detecting chronic kidney disease is not used enough in high-risk groups, study suggests

UC Davis Health offers third dose COVID-19 'booster' shots to immunocompromised patients

Excluding race factor from kidney function estimates may affect clinical outcomes for Black cancer patients

Study unlocks genetic treasure chest for chronic kidney disease

Oral drug found to be effective, safe for treating anemia in patients with chronic kidney disease

Clarity on covid count: Pandemic’s toll on seniors extended well beyond nursing homes

New model can help clinicians to predict 40-day mortality risk in hospitalized COVID-19 patients

Study compares the impacts of various race-free equations on kidney disease diagnoses

New concise recommendations for managing osteoporosis in patients with chronic kidney disease

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Chronic Kidney Disease News and Research

Latest Chronic Kidney Disease News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in